• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter to the Editor Regarding "Cardiovascular Insights for the Appropriate Management of Chronic Venous Disease: A Narrative Review of Implications for the Use of Venoactive Drugs".

作者信息

Poggialini Mauro, Travagli Valter

机构信息

Dipartimento Cardio-Toraco-Vascolare, Centro di Flebolinfologia, Azienda Ospedaliera-Universitaria Senese, Siena, Italy.

Dipartimento di Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, Siena, Italy.

出版信息

Adv Ther. 2024 Aug;41(8):3437-3438. doi: 10.1007/s12325-024-02931-9. Epub 2024 Jul 3.

DOI:10.1007/s12325-024-02931-9
PMID:38958841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11263377/
Abstract
摘要

相似文献

1
Letter to the Editor Regarding "Cardiovascular Insights for the Appropriate Management of Chronic Venous Disease: A Narrative Review of Implications for the Use of Venoactive Drugs".致编辑的信：关于“慢性静脉疾病合理管理的心血管见解：关于使用静脉活性药物的影响的叙述性综述”
Adv Ther. 2024 Aug;41(8):3437-3438. doi: 10.1007/s12325-024-02931-9. Epub 2024 Jul 3.
2
A Response to: Letter to the Editor Regarding "Cardiovascular Insights for the Appropriate Management of Chronic Venous Disease: A Narrative Review of Implications for the Use of Venoactive Drugs".对《致编辑的信：关于“慢性静脉疾病合理管理的心血管见解：关于使用活性静脉药物的影响的叙述性综述”》的回应
Adv Ther. 2024 Aug;41(8):3439-3440. doi: 10.1007/s12325-024-02934-6. Epub 2024 Jul 3.
3
Cardiovascular Insights for the Appropriate Management of Chronic Venous Disease: A Narrative Review of Implications for the Use of Venoactive Drugs.心血管洞察：慢性静脉疾病的合理管理：血管活性药物应用相关影响的叙述性综述。
Adv Ther. 2023 Dec;40(12):5137-5154. doi: 10.1007/s12325-023-02657-0. Epub 2023 Sep 28.
4
Is There a Difference in the Clinical Efficacy of Diosmin and Micronized Purified Flavonoid Fraction for the Treatment of Chronic Venous Disorders? Review of Available Evidence.地奥司明与微粒化纯化黄酮类混合物治疗慢性静脉疾病的临床疗效是否存在差异？现有证据回顾。
Vasc Health Risk Manag. 2021 Sep 16;17:591-600. doi: 10.2147/VHRM.S324112. eCollection 2021.
5
Micronized Purified Flavonoid Fraction (MPFF) for Patients Suffering from Chronic Venous Disease: A Review of New Evidence.微粉化纯化黄酮类混合物（MPFF）治疗慢性静脉疾病患者：新证据综述。
Adv Ther. 2019 Mar;36(Suppl 1):20-25. doi: 10.1007/s12325-019-0884-4. Epub 2019 Feb 13.
6
Meta-analysis of the impact of the principal venoactive drugs agents on malleolar venous edema.主要静脉活性药物制剂对踝关节静脉性水肿影响的荟萃分析
Int Angiol. 2012 Aug;31(4):310-5.
7
Pharmacological treatment of primary chronic venous disease: rationale, results and unanswered questions.原发性慢性静脉疾病的药物治疗：原理、结果及未解问题。
Eur J Vasc Endovasc Surg. 2011 Jan;41(1):117-25. doi: 10.1016/j.ejvs.2010.09.025. Epub 2010 Dec 3.
8
Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders.类黄酮。500毫克微粒化纯化黄酮成分（爱脉朗）治疗慢性静脉功能不全及相关疾病的药理学与疗效综述。
Angiology. 1994 Jun;45(6):419-28. doi: 10.1177/000331979404500602.
9
[Therapeutic potential of micronized purified flavonoid fraction (MPFF) of diosmin and hesperidin in treatment chronic venous disorder].地奥司明与橙皮苷微粉化纯化黄酮类成分（MPFF）在治疗慢性静脉疾病中的治疗潜力
Vnitr Lek. 2015 Sep;61(9):807-14.
10
Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids.微粉化纯化黄酮类成分：关于其在慢性静脉功能不全、静脉溃疡和痔疮治疗中应用的综述
Drugs. 2003;63(1):71-100. doi: 10.2165/00003495-200363010-00005.

引用本文的文献

1
A Response to: Letter to the Editor Regarding "Cardiovascular Insights for the Appropriate Management of Chronic Venous Disease: A Narrative Review of Implications for the Use of Venoactive Drugs".对《致编辑的信：关于“慢性静脉疾病合理管理的心血管见解：关于使用活性静脉药物的影响的叙述性综述”》的回应
Adv Ther. 2024 Aug;41(8):3439-3440. doi: 10.1007/s12325-024-02934-6. Epub 2024 Jul 3.

本文引用的文献

1
Cardiovascular Insights for the Appropriate Management of Chronic Venous Disease: A Narrative Review of Implications for the Use of Venoactive Drugs.心血管洞察：慢性静脉疾病的合理管理：血管活性药物应用相关影响的叙述性综述。
Adv Ther. 2023 Dec;40(12):5137-5154. doi: 10.1007/s12325-023-02657-0. Epub 2023 Sep 28.
2
The Effect of Diosmin, Escin, and Bromelain on Human Endothelial Cells Derived from the Umbilical Vein and the Varicose Vein-A Preliminary Study.地奥司明、七叶皂苷和菠萝蛋白酶对人脐静脉和曲张静脉来源的内皮细胞的影响——一项初步研究。
Biomedicines. 2023 Jun 13;11(6):1702. doi: 10.3390/biomedicines11061702.
3
Diosmin and its glycocalyx restorative and anti-inflammatory effects on injured blood vessels.地奥司明及其糖萼修复作用和对受损血管的抗炎作用。
FASEB J. 2022 Dec;36(12):e22630. doi: 10.1096/fj.202200053RR.
4
Diosmin therapy alters the in vitro metabolism of noradrenaline by the varicose human saphenous vein.地奥司明疗法改变了曲张大隐静脉对去甲肾上腺素的体外代谢。
Pharmacol Res. 1991 Oct;24(3):253-6. doi: 10.1016/1043-6618(91)90088-f.